Non Hodgkin Lymphoma Clinical Trial
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Summary
RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future.
PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.
Full Description
OBJECTIVES:
Provide source of patient tissue, blood, and body fluid samples for ongoing diagnostic, prognostic, or immune-monitoring studies.
Support and enhance translational, clinical and basic research for Lineberger Comprehensive Cancer Center (LCCC) members (and non-members who have an LCCC member as sponsor and collaborator) with IRB-approved studies.
Maintain responsible and appropriate policies and procedures that ensure good patient care and responsible conduct of research.
Address medical and legal issues, and protect participant and patient privacy and confidentiality.
Provide a responsible and uniform mechanism for the integrated coordination of the hemato-pathologist and surgeon or hematology/oncology staff, researcher, and protocol office to obtain appropriate specimens for researchers.
Support young investigators to obtain pilot data for grant funding.
OUTLINE: Patients undergo tissue, blood, and body fluid collection during diagnostic or routine procedures for future correlative studies. Tissue samples may include, but are not limited to, lymph node or non-nodal biopsies, bone marrow biopsy and/or aspirate, blood and serum, and buccal swabs for germline DNA analysis.
Eligibility Criteria
DISEASE CHARACTERISTICS:
Diagnosis of abnormal hematopoietic/lymphoid cancer, including any of the following:
Acute myeloid leukemia
Acute lymphoblastic leukemia
Chronic myelogenous leukemia
Chronic lymphoid leukemia
Non-Hodgkin lymphoma
Hodgkin lymphoma
Myelodysplastic syndromes
Myeloproliferative disorders
Multiple myeloma
Waldenstrom macroglobulinemia
Aplastic anemia
Any other diseases that generate abnormalities in either number, function, or both of any cell type of hematolymphoid lineage
Patients who are being evaluated at the hematology/oncology clinics of the University of North Carolina Hospitals, at the stem cell transplant clinic, or in the hospital
PATIENT CHARACTERISTICS:
Not specified
PRIOR CONCURRENT THERAPY:
Not specified
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Chapel Hill North Carolina, 27599, United States More Info
How clear is this clinincal trial information?